Low levels of telomerase activity have recently been detected in human
primitive hematopoietic cells, however, blood cells exhibit telomere
shortening on cell proliferation. This challenging observation led us
to study telomerase regulation and telomere length in human hematopoie
tic progenitor cells from fetal liver (FL), cord blood (CB), periphera
l blood (PB), and bone marrow (BM). We found telomerase activity in CD
34(+)/CD38(+) cells exceeding levels in CD34(+)/CD38(-), CD34(-), and
mononuclear cells (P <.05). Baseline telomerase activity was highest i
n BM (n = 5) CD34(+) cells, followed by PB (n = 20), CB (n = 11), and
FL (n = 1). Within 48 hours to 72 hours of in vitro culture of CD34(+)
cells in the presence of cytokines (KL, interleukin-3 [IL-3], IL-6, e
rythropoietin, granulocyte colony-stimulating factor), telomerase acti
vity was upregulated, peaked after 1 week of culture, and decreased to
baseline levels or below detection after 3 to 4 weeks. Stimulation of
CD34(+) cells with single cytokines resulted in no or minor telomeras
e upregulation, whereas cytokine combinations resulted in a significan
t telomerase increase (P <.001). There was a correlation between telom
erase activity, cell cycle status by BrdU incorporation, and induction
of phosphorylated retinoblastoma protein, CDC2, CDK2, cyclin D1, and
cyclin A, but not cyclin E and B1 after 72 hours with multiple (but no
t single) cytokines. In nonexpanding CD34(+) cells, telomerase was low
or undetectable. Secondary CD34(+) cells showed a reduced ability to
upregulate telomerase activity. Antiproliferative cytokines such as tr
ansforming growth factor-beta 1 and high concentrations of all-trans-r
etinoic acid in cytokine-supported CD34(+) cultures downmodulated telo
merase activity. Average telomere lengths were 10.4 kbp, 7.4 kbp, and
7.6 kbp in CB, PB, and BM CD34(+) cells, respectively. In ex vivo expa
nsion cultures, an average telomeric DNA loss of 1 to 2 kbp over 4 wee
ks was observed. However, the rate of base pair loss per population do
ubling was significantly lower during the first 2 weeks, when telomera
se was upregulated, than during weeks 3 and 4 of culture. In summary,
telomerase is upregulated in response to cytokine-induced proliferatio
n and cell cycle activation in primitive hematopoietic cells. Telomera
se is downregulated between weeks 3 and 4 of ex vivo expansion culture
linked with decreased proliferation and greater expansion of more mat
ure cell subsets, Our data suggest that telomerase activity in hematop
oietic cells reduces, but does not prevent, telomere shortening on pro
liferation. (C) 1997 by The American Society of Hematology.